fda bpc-157 compounding status 2026 Big news for the peptide space., The Pharmacy Advisory Committee recently voted eight to six in favor of allowing compounding pharmacies to produce BPC 157. Here is what you need to The majority of FDA's peptide
The majority of FDA's peptide review panel votes YES on compounding BPC 157. This is the first vote of the four peptides to be analyzed at today's PCAC meeting. While the committee can FDA's Review Of Peptides Signals A Growing Public Health Challenge The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link Big decisions could be coming for peptide compounding. Over the next few days, the FDA's Pharmacy Compounding Advisory Committee will discuss several peptides, including BPC 157, and whether they should be considered for FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog FDA Peptide Reclassification 2026: What Researchers Want
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3



